REPH RECRO PHARMA INC

Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

Conference Call and Webcast Scheduled for Monday, November 9, 2020 at 8:00 a.m. ET

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that it will report third quarter 2020 financial results on Monday, November 9, 2020. Recro’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Monday, November 9, 2020 to discuss the financial results and recent operational highlights.

To access the conference call please dial (844) 243-4691(local) or (225) 283-0379 (international) at least 10 minutes prior to the start time and refer to conference ID 9677189. A live audio webcast of the call will be available under "Events" in the Investor section of the Company's website, . An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days.

About Recro

Recro is a contract development and manufacturing, or CDMO, business, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, with its operations location in Gainesville, GA. Recro recently launched its Clinical Trials Materials and Logistics business, including preparation of double-blind clinical trial supplies and also offers specialized services dedicated to the development and GMP manufacturing of high potency products. The Company leverages its formulation expertise to develop and manufacture pharmaceutical products using its proprietary delivery technologies and other manufacturing services for commercial and development-stage partners who commercialize or plan to commercialize these products. For more information see .

Contacts

Investor Relations Contacts:

Argot Partners

Sam Martin / Claudia Styslinger

(212) 600-1902



Recro

Ryan D. Lake

(484) 395-2436

Media Contact:

Argot Partners

David Rosen

(212) 600-1902

EN
02/11/2020

Underlying

REPHRECRO PHARMA INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RECRO PHARMA INC

 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc. CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics. The Offer and the MergerCoreRx’s tender offer to acquire all of the issued and outstanding shares of common stock (the “Shares”) of Societal CDMO, at a purchase price of $1.1...

April 8, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreR...

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc. Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATER, Fla. and GAINESVILLE, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufa...

February 28, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Prom...

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. and ROUND ROCK, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: ), a contract development and manufacturing organization (CDMO) de...

February 1, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Reports Inducement Grants for New Staff

Societal CDMO Reports Inducement Grants for New Staff SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization. Inducement Equity Award In connection with the hiring of these personnel, the compensation committee of Societal CDMO’s board of directors approve...

January 5, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Reports Third Quarter 2023 Financial Results

Societal CDMO Reports Third Quarter 2023 Financial Results Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approximately $5.5 Million Company to Host Webcast Today at 4:30 p.m. ET SAN DIEGO and GAINESVILLE, Ga., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solvin...

November 8, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch